João’s research focuses on nanotechnologies for oral drug delivery. At Controlled Release Society conference 2021, he will discuss in the CRS Focus Group in Oral Drug Delivery a pH-responsive NP platform targeted to the neonatal Fc receptor (FcRn), which stabilizes insulin in the GI tract while improving intestinal cell interaction and uptake.
Congratulations João! We are extremely proud of your amazing achievement and well deserved award.
Another award to the Santos' Lab portfolio!